Literature DB >> 33032241

TNF contributes to T-cell exhaustion in chronic L. mexicana infections of mice through PD-L1 up-regulation.

Eddie González-Tafoya1, Mariana Diupotex1, Jaime Zamora-Chimal1, Norma Salaiza-Suazo1, Adriana Ruiz-Remigio1, Ingeborg Becker2.   

Abstract

Leishmania mexicana can produce chronic infections leading to exhausted T cell phenotypes, mediated by PD-1/PD-L1. Little is known on mechanisms that induce these inhibitory molecules in chronic leishmaniasis. We analyzed factors that contribute to exhausted phenotypes in chronic L. mexicana infections of mice. Our results show that draining lymph node cells express enhanced levels of PD-1/PD-L1. T lymphocytes producing low cytokine levels were also found. L. mexicana infection of dendritic cells (DCs) produced elevated amounts of TNF and showed up-regulation of PD-L1 expression. We provide evidence that T cells of chronic L. mexicana infections in mice are functionally exhausted due to chronic TNF production, which leads to PD-L1 up-regulation in DCs. We conclude that TNF has a fundamental role in promoting T cell exhaustion during chronic L. mexicana infections, which contributes to the inability of T cells to proliferate and produce pro-inflammatory cytokines, thus favoring disease progression.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic infection; Exhausted phenotype; Leishmania mexicana; Mouse model; PD-1; PD-L1; TNF

Mesh:

Substances:

Year:  2020        PMID: 33032241     DOI: 10.1016/j.cellimm.2020.104196

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

Review 1.  T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis.

Authors:  Juliana C Costa-Madeira; Gabrielly B Trindade; Paulo H P Almeida; João S Silva; Vanessa Carregaro
Journal:  Front Immunol       Date:  2022-05-02       Impact factor: 8.786

Review 2.  Host-Directed Therapies for Cutaneous Leishmaniasis.

Authors:  Fernanda O Novais; Camila Farias Amorim; Phillip Scott
Journal:  Front Immunol       Date:  2021-03-26       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.